Opportunity Information: Apply for RFA RR 11 004
Apply for RFA RR 11 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.389 National Center for Research Resources.
- This funding opportunity was created on Jun 14, 2011 and posted on Mar 25, 2011.
- Applicants must submit their applications by Jun 28, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education Public and State controlled institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non U.S.) components of U.S. Organizations are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The National Center for Research Resources (NCRR), within the National Institutes of Health (NIH), offered a limited-competition grant opportunity titled "Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1)" under Funding Opportunity Number RFA-RR-11-004. The purpose of this announcement was to encourage Clinical and Translational Science Award (CTSA) institutions to submit competitive revision applications that would add or expand collaborative translational science projects. The focus was specifically on projects with clear clinical significance that involve multiple CTSA institutions working together, with the intent of accelerating translation of research findings into clinical applications through coordinated, multi-site efforts. Importantly, the opportunity was restricted to competitive revisions to the UL1 component of an existing CTSA award, meaning it was not a stand-alone new award mechanism but rather an add-on (revision) request tied to an active CTSA UL1 grant.
This funding opportunity was issued as a discretionary cooperative agreement, reflecting NIH's expectation of substantial programmatic involvement from the agency during the project period, consistent with how cooperative agreements typically operate. The activity categories listed were education and health, aligning with the CTSA program's overall mission to strengthen the national translational research enterprise, including infrastructure, training, and applied clinical research capabilities. The announcement anticipated making approximately four awards, with an estimated total funding level of $2,000,000. Individual awards were capped at an award ceiling of $500,000, and there was no cost sharing or matching requirement, which means applicants were not required to contribute institutional funds as a condition of receiving the award.
Eligibility was aimed primarily at institutions of higher education, including both public/state-controlled and private institutions. The announcement also explicitly included as eligible applicants several categories of institutions that are often highlighted in federal programs focused on broad participation, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving Institutions. At the same time, it made clear that non-U.S. (foreign) organizations were not eligible to apply, and foreign components of U.S. organizations were not allowed, reinforcing that the proposed collaborative work needed to be conducted within eligible U.S.-based institutional structures associated with CTSA hubs.
Key dates for the opportunity indicate it was posted on March 25, 2011, created on June 14, 2011, with an original application closing date of May 26, 2011 that was later extended to a current closing date of June 28, 2011. The archive date was July 28, 2011, indicating the opportunity is no longer active and is provided for historical/reference purposes. Applicants and interested parties were directed to the full announcement hosted on the NIH Grants Guide website, and technical assistance for accessing or linking to the announcement was available through the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.
In practical terms, this opportunity was designed to quickly stimulate high-impact, cross-CTSA collaborations by providing additional UL1 resources to ongoing CTSA awards, emphasizing translational projects that could benefit from multi-institutional coordination and that were positioned to generate clinically meaningful outcomes.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled "Limited Competition for Competitive Revision Applications to Accelerate and Enhance Collaborative Translational Science (UL1)."
What is the funding opportunity number (FON)?
The funding opportunity number is RFA-RR-11-004.
Which agency and NIH center offered this opportunity?
This opportunity was offered by the National Center for Research Resources (NCRR) within the National Institutes of Health (NIH).
What was the main purpose of this announcement?
The purpose was to encourage Clinical and Translational Science Award (CTSA) institutions to submit competitive revision applications that would add or expand collaborative translational science projects.
What kind of projects were emphasized?
The focus was on collaborative translational science projects with clear clinical significance, involving multiple CTSA institutions working together to accelerate translation of research findings into clinical applications through coordinated, multi-site efforts.
Was this a new, stand-alone grant mechanism?
No. It was restricted to competitive revisions to the UL1 component of an existing CTSA award. It functioned as an add-on (revision) request tied to an active CTSA UL1 grant rather than a stand-alone new award.
What does it mean that this was a "limited competition" opportunity?
Based on the announcement description, the opportunity was limited to CTSA institutions submitting competitive revisions to an existing CTSA UL1 award, rather than being open to all applicants for a brand-new award.
What award type or funding mechanism was used?
This opportunity was issued as a discretionary cooperative agreement, reflecting NIH's expectation of substantial programmatic involvement from the agency during the project period.
What does a cooperative agreement imply for NIH involvement?
It indicates NIH anticipated substantial programmatic involvement during the project period, consistent with how cooperative agreements typically operate.
What activity categories were associated with this opportunity?
The listed activity categories were education and health, aligning with the CTSA program mission related to infrastructure, training, and applied clinical research capabilities within translational science.
How many awards were anticipated?
The announcement anticipated making approximately four awards.
What was the estimated total funding level?
The estimated total funding level was $2,000,000.
What was the maximum award amount per award?
Individual awards were capped at an award ceiling of $500,000.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement, meaning applicants were not required to contribute institutional funds as a condition of receiving the award.
Who was eligible to apply?
Eligibility was aimed primarily at institutions of higher education, including public/state-controlled and private institutions.
Were specific institution types explicitly included as eligible?
Yes. The announcement explicitly included as eligible applicants Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and Alaska Native and Native Hawaiian-serving Institutions.
Were non-U.S. (foreign) organizations eligible to apply?
No. Non-U.S. (foreign) organizations were not eligible to apply.
Were foreign components of U.S. organizations allowed?
No. Foreign components of U.S. organizations were not allowed.
Does the opportunity indicate where the collaborative work needed to be conducted?
It reinforces that the proposed collaborative work needed to be conducted within eligible U.S.-based institutional structures associated with CTSA hubs.
What were the key dates for this opportunity?
The opportunity was posted on March 25, 2011, created on June 14, 2011, had an original application closing date of May 26, 2011, and was later extended to a closing date of June 28, 2011. The archive date was July 28, 2011.
Was the application deadline extended?
Yes. The original closing date of May 26, 2011 was extended to June 28, 2011.
Is this funding opportunity still active?
No. The archive date of July 28, 2011 indicates the opportunity is no longer active and is provided for historical/reference purposes.
Where could applicants find the full announcement?
Applicants and interested parties were directed to the full announcement hosted on the NIH Grants Guide website.
Where could someone get technical help related to accessing or linking to the announcement?
Technical assistance for accessing or linking to the announcement was available through the NIH Office of Extramural Research (OER) webmaster contact listed in the notice.
What practical goal did this opportunity aim to achieve?
It was designed to quickly stimulate high-impact, cross-CTSA collaborations by providing additional UL1 resources to ongoing CTSA awards, emphasizing translational projects positioned to generate clinically meaningful outcomes through multi-institutional coordination.
What was the specific CTSA grant component targeted by this announcement?
The opportunity specifically targeted competitive revisions to the UL1 component of an existing CTSA award.
What kind of collaboration was expected?
The announcement emphasized coordinated, multi-site efforts involving multiple CTSA institutions working together on translational science projects with clear clinical significance.
Browse more opportunities from the same category: Education Health
Next opportunity: Systems Approach to Immunity and Inflammation (U19)
Previous opportunity: FY 2011 Request for Proposals for the Pollution Prevention Information Network (PPIN) Grants Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA RR 11 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA RR 11 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Short Term Research Enhancement Opportunities for Veterinarians (K18) Apply for RFA RR 11 002 Funding Number: RFA RR 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development Program Projects for Substance Related Disorders (P01) Apply for RFA DA 12 005 Funding Number: RFA DA 12 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Education Program for Laboratory Animal Medicine Veterinarians (R25) Apply for RFA RR 11 003 Funding Number: RFA RR 11 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Systems Biology Approaches in HIV/AIDS and Substance Use (R01) Apply for RFA DA 12 009 Funding Number: RFA DA 12 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $650,000 |
| National Cooperative Drug Discovery and Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) Apply for PAR 11 206 Funding Number: PAR 11 206 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) Apply for PAR 11 207 Funding Number: PAR 11 207 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NLM Express Research Grants in Biomedical Informatics (R01) Apply for PAR 11 208 Funding Number: PAR 11 208 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| NLM Advanced Informatics for Health (R01) Apply for RFA LM 11 002 Funding Number: RFA LM 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| New Technology for Proteomics and Glycomics (STTR R41/R42) Apply for PA 11 214 Funding Number: PA 11 214 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| New Technology for Proteomics and Glycomics (SBIR R43/R44) Apply for PA 11 215 Funding Number: PA 11 215 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Integration of Drug Abuse Prevention and Treatment in Primary Care Settings (R01) Apply for RFA DA 12 008 Funding Number: RFA DA 12 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Remote Monitoring System for Detecting Cocaine Ingestion/Intoxication (R01) Apply for RFA DA 12 007 Funding Number: RFA DA 12 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Community Clinical Oncology Program Groups (U10) Apply for RFA CA 11 006 Funding Number: RFA CA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Community Clinical Oncology Program Research Bases (U10) Apply for RFA CA 11 007 Funding Number: RFA CA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Minority Based Community Clinical Oncology Program Groups (U10) Apply for RFA CA 11 008 Funding Number: RFA CA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Early Phase Clinical Trials in Imaging and Image Guided Interventions (R21) Apply for PAR 11 216 Funding Number: PAR 11 216 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Cancer Target Discovery and Development (CTDD) Network (U01) Apply for RFA CA 11 010 Funding Number: RFA CA 11 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R01) Apply for RFA MH 12 060 Funding Number: RFA MH 12 060 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Promoting Engagement in Care and Timely Antiretroviral Initiation Following HIV Diagnosis (R34) Apply for RFA MH 12 061 Funding Number: RFA MH 12 061 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| High End Instrumentation Grant Program (S10) Apply for PAR 11 228 Funding Number: PAR 11 228 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA RR 11 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.